Covid Patent Landscape
Human civilization is at a juncture where the entire world is praying to get rid of home quarantine and all talented researchers are finding ways to quarantine the lethal COVID-19. The COVID-19 is going to be most infectious virus of the era. The COVID-19 has shown strange characteristics in terms of morbidity and mortality in various demographic locations. At present, there is no vaccine available to cure this disease. However, many attempts have been taken and many patent applications have been filed pertaining to this particular Corona Virus across the globe. This landscape exercise is to identify the relevant active and efficient patents or patent applications and Non-patent Literature that could help positioning of target compound or molecules or cure, potential commercialization pipeline, sale, or use of the research findings across the globe.
COVID-19 is a new pathogen first identified in recent Wuhan epidemic and is called coronavirus disease 2019 (COVID-19). COVID-19 belongs to family Coronaviridae in the order Nidovirale. Currently, there are four genera in the subfamily Coronavirinae of the family Coronaviridae: Alphacoronavirus, Betacoronavirus, Deltacoronavirus and Gammacoronavirus. Before the current COVID-19 epidemic, there were six recognised human respiratory coronaviruses, including HCoV-229E (Alphacoronavirus ), HCoV-OC43 (Betacoronavirus), HCoV-NL63 (Alphacoronavirus ) and HKU1 (Betacoronavirus) that often cause mild respiratory tract infection as well as SARSCoV and MERS-CoV which in contrast can lead to severe or even fatal lower respiratory tract disease. The seventh human coronavirus, SARS-CoV-2, belongs to the genus Betacoronavirus, which also contains SARS-CoV and MERS-CoV.
Coronaviruses (CoVs) are relatively large viruses containing a single-stranded positive-sense RNA genome encapsulated within a membrane envelope. The viral membrane is studded with glycoprotein spikes that give coronaviruses their crownlike appearance.